Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Debt to Equity: 2024-2025

Historic Debt to Equity for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $0.04.

  • Kura Oncology's Debt to Equity rose 78.43% to $0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.16, marking a year-over-year change of. This contributed to the annual value of $0.02 for FY2024, which is N/A change from last year.
  • As of Q3 2025, Kura Oncology's Debt to Equity stood at $0.04, which was up 26.63% from $0.03 recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Debt to Equity peaked at $0.04 during Q3 2025, and registered a low of $0.02 during Q1 2024.